KPRX 最新10-Q变化

相对上期新增的文字 · 来源:10-Q · 2026-08-07

• mutation associated with retinitis pigmentosa. Enrollment began in the second quarter of 2025 and dosing began in the third quarter of 2025.

• General and Administrative Expenses. The increase of $29.7 thousand was driven primarily by higher professional services.

• Income Tax Provision. The decrease of $0.1 million is due to a change in estimate for 2024 tax year resulting from new legislation included in the One Big Beautiful Bill Act (OBBBA) realized in 2025.

• The following table summarizes the results of our operations for the six months ended June 30, 2026 and 2025:

• General and Administrative Expenses. The increase of $0.2 million was primarily due to increased professional services expenses driven by patent related legal expenses.

相对上期删除的文字 · 来源:10-Q · 2026-05-08

• General and Administrative Expenses. The increase of $0.1 million was driven primarily by increased director and personnel costs related to salary and equity expenses and higher professional services.

• Other Income, Net. The decrease of $0.2 million was primarily due to lower interest income resulting from lower interest rates and a lower carrying balance of short-term marketable securities and unrealized losses related to foreign currency activity.

• Income Tax Provision. The increase of $0.1 million is due to a change in estimate for 2024 tax year resulting from new legislation included in the One Big Beautiful Bill Act (OBBBA) realized in 2025.

• If we raise additional funds by issuing equity securities or convertible debt, our stockholders will experience dilution. Debt financing through our $10 million credit line with UBS would result in increased fixed payment obligations and may involve agreements that include covenants limiting or rest…

• collaboration and licensing arrangements with third parties, it may be necessary to relinquish valuable rights to our products, future revenue streams or product candidates, or to grant licenses on terms that may not be favorable to us. Although historically we have been successful at raising capita…

相对上期新增的文字 · 来源:10-Q · 2026-08-07

• In May 2026, Brian M. Strem, the Company's Chief Executive Officer, and Melissa Tosca, the Company's Chief Financial Officer, adopted pre-arranged “sell-to-cover” Rule 10b5-1 instructions, as defined in Rule 16a-1(f), to sell shares of common stock to the extent necessary to cover tax withholding on…

相对上期删除的文字 · 来源:10-Q · 2026-05-08

• No officers or directors, as defined in Rule 16a-1(f), adopted, modified or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement as defined in item 408 of Regulation S-K, during the period ended March 31, 2026.